Precocious puberty and leydig cell hyperplasia in male mice with a gain of function mutation in the LH receptor gene

Endocrinology

Volumn 154, Issue 10, 2013, Pages 3900-3913

  McGee, Stacey R ^a   Narayan, Prema ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3BETA HYDROXY DELTA5 STEROID DEHYDROGENASE; ASPARTIC ACID; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); CYCLIC AMP; ESTROGEN SULFOTRANSFERASE; GLYCINE; GONADOTROPIN; LUTEINIZING HORMONE; MESSENGER RNA; TESTOSTERONE; TESTOSTERONE 17BETA DEHYDROGENASE; THROMBOSPONDIN;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CELL DIFFERENTIATION; CELL HYPERPLASIA; CELL MATURATION; CONTROLLED STUDY; GAIN OF FUNCTION MUTATION; GENETIC TRANSFECTION; GERM CELL; HETEROZYGOSITY; LEYDIG CELL; MALE; MOUSE; NONHUMAN; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR GENE; SERTOLI CELL; SIGNAL TRANSDUCTION; TESTOSTERONE BLOOD LEVEL; UPREGULATION;

AMINO ACID SUBSTITUTION; ANIMALS; CELL PROLIFERATION; CROSSES, GENETIC; DISEASE MODELS, ANIMAL; GENE KNOCK-IN TECHNIQUES; HUMANS; HYPERPLASIA; LEYDIG CELLS; MALE; MICE; MICE, 129 STRAIN; MICE, MUTANT STRAINS; MUTAGENESIS, SITE-DIRECTED; MUTANT PROTEINS; PUBERTY, PRECOCIOUS; RECEPTORS, LH; TESTICULAR DISEASES; TESTOSTERONE; UP-REGULATION;

EID: 84884694539     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-2179     Document Type: Article

References (72)

1. Gromoll J, Eiholzer U, Nieschlag E, Simoni M. Male hypogonadism caused by homozygous deletion of exon 10 of the luteinizing hormone (LH) receptor: differential action of human chorionic gonadotropin and LH. J Clin Endocrinol Metab. 2000;85:2281-2286. (Pubitemid 32269256)
2. Themmen APN, Huhtaniemi IT. Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr Rev. 2000;21:551-583.
3. Yao HH-C, Barsoum I. Fetal Leydig cells: origin, regulation and functions. In: Payne AH, Hardy MP, eds. The Leydig Cell in Health and Disease. Totawa, New Jersey: Humana Press; 2007:47-54.
4. Ge R, Hardy MP. Regulation of Leydig cells during pubertal development. In: Payne AH, Hardy MP, eds. The Leydig Cell in Health and Disease. Totawa, New Jersey: Humana Press; 2007:55-70.
5. Ascoli M, Fanelli F, Segaloff DL. The lutropin/choriogonadotropin receptor, a 2002 perspective. Endocr Rev. 2002;23:141-174. (Pubitemid 34299022)
6. Dufau ML. The luteinizing hormone receptor. Annu Rev Physiol. 1998;60:461-496. (Pubitemid 28157883)
7. Evaul K, Hammes SR. Cross-talk between G protein-coupled and epidermal growth factor receptors regulates gonadotropin-mediated steroidogenesis in Leydig cells. J Biol Chem. 2008;283:27525-27533.
8. Martinelle N, Holst M, Söder O, Svechnikov K. Extracellular signal-regulated kinases are involved in the acute activation of steroidogenesis in immature rat Leydig cells by human chorionic gonadotropin. Endocrinology. 2004;145:4629-4634. (Pubitemid 39281455)
9. Shiraishi K, Ascoli M. Lutropin/Choriogonadotropin stimulate the proliferation of primary cultures of rat Leydig cells through a pathway that involves activation of the extracellularly regulated kinase 1/2 cascade. Endocrinology. 2007;148:3214-3225. (Pubitemid 46997014)
10. Tai P, Shiraishi K, Ascoli M. Activation of the lutropin/ choriogonadotropin receptor inhibits apoptosis of immature Leydig cells in primary culture. Endocrinology. 2009;150:3766-3773.
11. Yamashita S, Tai P, Charron J, Ko C, Ascoli M. The Leydig cell MEK/ERK pathway is critical for maintaining a functional population of adult Leydig cells and for fertility. Mol Endocrinol. 2011;25:1211-1222.
12. Latronico AC, Segaloff DL. Naturally occurring mutations of the luteinizing-hormone receptor: lessons learned about reproductive physiology and G protein-coupled receptors. Am J Hum Genet. 1999;65:949-958. (Pubitemid 30462951)
13. Themmen AP. An update of the pathophysiology of human gonadotrophin subunit and receptor gene mutations and polymorphisms. Reproduction. 2005;130:263-274. (Pubitemid 41320751)
14. Gondos B, Egli CA, Rosenthal SM, Grumbach MM. Testicular changes in gonadotropin-independent familial male sexual precocity. Familial testotoxicosis. Arch Pathol Lab Med. 1985;109:990-995. (Pubitemid 16231410)
15. Schedewie HK, Reiter EO, Beitins IZ, et al. Testicular Leydig cell hyperplasia as a cause of familial sexual precocity. J Clin Endocrinol Metab. 1981;52:271-278. (Pubitemid 11183624)
16. Rosenthal SM, Grumbach MM, Kaplan SL. Gonadotropin-independent familial sexual precocity with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent luteinizing hormone-releasing factor agonist and medroxyprogesterone acetate therapy in four cases. J Clin Endocrinol Metab. 1983;57:571-579. (Pubitemid 13005524)
17. Wu SM, Leschek EW, Rennert OM, Chan WY. Luteinizing hormone receptor mutations in disorders of sexual development and cancer. Front Biosci. 2000;5:D343-D352.
18. Canto P, Söderlund D, Ramón G, Nishimura E, Méndez JP. Mutational analysis of the luteinizing hormone receptor gene in two individuals with leydig cell tumors. Am J Med Genet. 2001;108:148-152.
19. Liu G, Duranteau L, Carel JC, Monroe J, Doyle DA, Shenker A. Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor. N Engl J Med. 1999;341:1731-1736.
20. Richter-Unruh A, Wessels HT, Menken U, et al. Male LH-independent sexual precocity in a 3.5-year-old boy caused by a somatic activating mutation of the LH receptor in a Leydig cell tumor. J Clin Endocrinol Metab. 2002;87:1052-1056. (Pubitemid 36121064)
21. Narayan P, Gray J, Puett D. Yoked complexes of human choriogonadotropin and the lutropin receptor: evidence that monomeric individual subunits are inactive. Mol Endocrinol. 2002;16:2733-2745. (Pubitemid 36024178)
22. Limbird LE. Cell Surface Receptors, a Short Course on Theory and Methods. 3rd ed. New York, New York: Springer; 2004.
23. Puett D, Angelova K. Determining the affinity of hormone-receptor interaction. Methods Mol Biol. 2009;590:1-20.
24. Vesper AH, Raetzman LT, Camper SA. Role of prophet of Pit1 (PROP1) in gonadotrope differentiation and puberty. Endocrinology. 2006;147:1654-1663.
25. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods. 2001;25:402-408. (Pubitemid 34164012)
26. Meehan TP, Harmon BG, Overcast ME, et al. Gonadal defects and hormonal alterations in transgenic mice expressing a single chain human chorionic gonadotropin-lutropin receptor complex. J Mol Endocrinol. 2005;34:489-503. (Pubitemid 40585197)
27. Koo YB, Ji I, Ji TH. Characterization of different sizes of rat luteinizing hormone/chorionic gonadotropin receptor messenger ribonucleic acids. Endocrinology. 1994;134:19-26. (Pubitemid 24021964)
28. Tsai-Morris CH, Buczko E, Wang W, Dufau ML. Intronic nature of the rat luteinizing hormone receptor gene defines a soluble receptor subspecies with hormone binding activity. J Biol Chem. 1990;265:19385-19388. (Pubitemid 120013871)
29. Zhang FP, Hämäläinen T, Kaipia A, Pakarinen P, Huhtaniemi I. Ontogeny of luteinizing hormone receptor gene expression in the rat testis. Endocrinology. 1994;134:2206-2213. (Pubitemid 24142964)
30. Korenbrot CC, Huhtaniemi IT, Weiner RI. Preputial separation as an external sign of pubertal development in the male rat. Biol Reprod. 1977;17:298-303. (Pubitemid 8171796)
31. Knopf JL, Gallagher JF, Held WA. Differential, multihormonal regulation of the mouse major urinary protein gene family in the liver. Mol Cell Biol. 1983;3:2232-2240. (Pubitemid 14224708)
32. Szoka PR, Paigen K. Regulation of mouse major urinary protein production by the Mup-A gene. Genetics. 1978;90:597-612. (Pubitemid 9087533)
33. O'Shaughnessy PJ, Willerton L, Baker PJ. Changes in Leydig cell gene expression during development in the mouse. Biol Reprod. 2002;66:966-975. (Pubitemid 34263116)
34. Baker PJ, Johnston H, Abel M, Charlton HM, O'Shaughnessy PJ. Differentiation of adult-type Leydig cells occurs in gonadotrophin-deficient mice. Reprod Biol Endocrinol. 2003;1:4.
35. Payne AH, Hales DB. Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev. 2004;25:947-970. (Pubitemid 39657774)
36. Clegg ED, Cook JC, Chapin RE, Foster PM, Daston GP. Leydig cell hyperplasia and adenoma formation: mechanisms and relevance to humans. Reprod Toxicol. 1997;11:107-121. (Pubitemid 27152426)
37. Cook JC, Klinefelter GR, Hardisty JF, Sharpe RM, Foster PM. Rodent Leydig cell tumorigenesis: a review of the physiology, pathology, mechanisms, and relevance to humans. Crit Rev Toxicol. 1999;29:169-261. (Pubitemid 29169595)
38. 578 in maintaining the inactive conformation of the human lutropin/choriogonadotropin receptor. J Biol Chem. 1996;271:31813-31817.
39. Shenker A, Laue L, Kosugi S, Merendino JJ Jr, Minegishi T, Cutler GB Jr. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature. 1993;365:652-654. (Pubitemid 23350536)
40. Pakarainen T, Ahtiainen P, Zhang FP, Rulli S, Poutanen M, Huhtaniemi I. Extragonadal LH/hCG action-Not yet time to rewrite textbooks. Mol Cell Endocrinol. 2007;269:9-16. (Pubitemid 46486762)
41. Rao CV, Lei ZM. The past, present and future of nongonadal LH/hCG actions in reproductive biology and medicine. Mol Cell Endocrinol. 2007;269:2-8. (Pubitemid 46483826)
42. Heller CG, Clermont Y. Kinetics of germinal epithelium in man. Rec Prog Horm Res. 1964;20:545-575.
43. Hazra R, Corcoran L, Robson M, et al. Temporal role of sertoli cell androgen receptor expression in spermatogenic development. Mol Endocrinol. 2013;27:12-24.
44. Allan CM, Garcia A, Spaliviero J, et al. Complete Sertoli cell proliferation induced by follicle-stimulating hormone (FSH) independently of luteinizing hormone activity: evidence from genetic models of isolated FSH action. Endocrinology. 2004;145:1587-1593. (Pubitemid 38402364)
45. Dierich A, Sairam MR, Monaco L, et al. Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc Natl Acad Sci USA. 1998;95:13612-13617. (Pubitemid 28523020)
46. Kumar TR, Wang Y, Lu N, Matzuk MM. Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nat Genet. 1997;15:201-204. (Pubitemid 27061644)
47. Singh J, O'Neill C, Handelsman DJ. Induction of spermatogenesis by androgens in gonadotropin-deficient (hpg) mice. Endocrinology. 1995;136:5311-5321.
48. Rulli SB, Ahtiainen P, Mäkelä S, Toppari J, Poutanen M, Huhtaniemi I. Elevated steroidogenesis, defective reproductive organs, and infertility in transgenic male mice overexpressing human chorionic gonadotropin. Endocrinology. 2003;144:4980-4990. (Pubitemid 37378413)
49. Simanainen U, McNamara K, Davey RA, Zajac JD, Handelsman DJ. Severe subfertility in mice with androgen receptor inactivation in sex accessory organs but not in testis. Endocrinology. 2008;149:3330-3338. (Pubitemid 351919613)
50. Krutskikh A, De Gendt K, Sharp V, Verhoeven G, Poutanen M, Huhtaniemi I. Targeted inactivation of the androgen receptor gene in murine proximal epididymis causes epithelial hypotrophy and obstructive azoospermia. Endocrinology. 2011;152:689-696.
51. Cattanach BM, Iddon CA, Charlton HM, Chiappa SA, Fink G. Gonadotrophin-releasing hormone deficiency in a mutant mouse with hypogonadism. Nature. 1977;269:338-340. (Pubitemid 8178658)
52. Kendall SK, Samuelson LC, Saunders TL, Wood RI, Camper SA. Targeted disruption of the pituitary glycoprotein hormone α-subunit produces hypogonadal and hypothyroid mice. Genes Dev. 1995;9:2007-2019.
53. Lei ZM, Mishra S, Zou W, et al. Targeted disruption of luteinizing hormone/human chorionic gonadotropin receptor gene. Mol Endocrinol. 2001;15:184-200. (Pubitemid 32156051)
54. Zhang FP, Poutanen M, Wilbertz J, Huhtaniemi I. Normal prenatal but arrested postnatal sexual development of luteinizing hormone receptor knockout (LuRKO) mice. Mol Endocrinol. 2001;15:172-183. (Pubitemid 32156050)
55. Baker PJ, Sha JH, O'Shaughnessy PJ. Localisation and regulation of 17β-hydroxysteroid dehydrogenase type 3 mRNA during development in the mouse testis. Mol Cell Endocrinol. 1997;133:127-133. (Pubitemid 27491525)
56. O'Shaughnessy PJ, Baker PJ, Heikkilä M, Vainio S, McMahon AP. Localization of 17β-hydroxysteroid dehydrogenase/17-ketosteroid reductase isoform expression in the developing mouse testis-androstenedione is the major androgen secreted by fetal/neonatal leydig cells. Endocrinology. 2000;141:2631-2637. (Pubitemid 32273174)
57. Shima Y, Miyabayashi K, Haraguchi S, et al. Contribution of leydig and sertoli cells to testosterone production in mouse fetal testes. Mol Endocrinol. 2013;27:63-73.
58. Ahtiainen P, Rulli SB, Shariatmadari R, et al. Fetal but not adult Leydig cells are susceptible to adenoma formation in response to persistently high hCG level: a study on hCG overexpressing transgenic mice. Oncogene. 2005;24:7301-7309. (Pubitemid 41622234)
59. Baker PJ, Sha JA, McBrideMW,Peng L, Payne AH, O'Shaughnessy PJ. Expression of 3β-hydroxysteroid dehydrogenase type I and type VI isoforms in the mouse testis during development. Eur J Biochem. 1999;260:911-917.
60. Payne AH, Sha LL. Multiple mechanisms for regulation of 3β-hydroxysteroid dehydrogenase/δ 5 - δ 4-isomerase, 17α-hydroxylase/C17-20 lyase cytochrome P450, and cholesterol side-chain cleavage cytochrome P450 messenger ribonucleic acid levels in primary cultures of mouse Leydig cells. Endocrinology. 1991;129:1429-1435.
61. Tsai-Morris CH, Khanum A, Tang PZ, Dufau ML. The rat 17β- hydroxysteroid dehydrogenase type III: molecular cloning and gonadotropin regulation. Endocrinology. 1999;140:3534-3542. (Pubitemid 30648840)
62. Pratis K, O'Donnell L, Ooi GT, McLachlan RI, Robertson DM. Enzyme assay for 5α-reductase type 2 activity in the presence of 5α-reductase type 1 activity in rat testis. J Steroid Biochem Mol Biol. 2000;75:75-82. (Pubitemid 32155426)
63. Viger RS, Robaire B. Steady state steroid 5α-reductase messenger ribonucleic acid levels and immunocytochemical localization of the type 1 protein in the rat testis during postnatal development. Endocrinology. 1995;136:5409-5415.
64. Pratis K, O'Donnell L, Ooi GT, Stanton PG, McLachlan RI. Differential regultion of rat testicular 5a-reductase type 1 and 2 isoforms by testosterone and FSH. J Endocrinol. 2003;176:393-403. (Pubitemid 36410422)
65. Meehan TP, Narayan P. Constitutively active luteinizing hormone receptors: consequences of in vivo expression. Mol Cell Endocrinol. 2007;260-262:294-300. (Pubitemid 44792345)
66. Matzuk MM, DeMayo FJ, Hadsell LA, Kumar TR. Overexpression of human chorionic gonadotropin causes multiple reproductive defects in transgenic mice. Biol Reprod. 2003;69:338-346. (Pubitemid 36806840)
67. Richter-Unruh A, Jorch N, Wessels HT, Weber EA, Hauffa BP. Venous sampling can be crucial in identifying the testicular origin of idiopathic male luteinising hormone-independent sexual precocity. Eur J Pediatr. 2002;161:668-671. (Pubitemid 35435540)
68. Ascoli M. Potential Leydig cell mitogenic signals generated by the wild-type and constitutively active mutants of the lutropin/choriogonadotropin receptor (LHR). Mol Cell Endocrinol. 2007;260-262:244-248. (Pubitemid 44792356)
69. Boot AM, Lumbroso S, Verhoef-Post M, et al. Mutation analysis of the LH receptor gene in Leydig cell adenoma and hyperplasia and functional and biochemical studies of activating mutations of the LH receptor gene. J Clin Endocrinol Metab . 2011;96:E1197-E1205.
70. Martin MM, Wu SM, Martin AL, Rennert OM, Chan WY. Testicular seminoma in a patient with a constitutively activating mutation of the luteinizing hormone/chorionic gonadotropin receptor. Eur J Endocrinol. 1998;139:101-106. (Pubitemid 28351243)
71. Leschek EW, Chan WY, Diamond DA, et al. Nodular Leydig cell hyperplasia in a boy with familial male-limited precocious puberty. J Pediatr. 2001;138:949-951. (Pubitemid 32545611)
72. Egli CA, Rosenthal SM, Grumbach MM, Montalvo JM, Gondos B. Pituitary gonadotropin-independent male-limited autosomal dominant sexual precocity in nine generations: familial testotoxicosis. J Pediatr. 1985;106:33-40. (Pubitemid 15189904)